Matches in SemOpenAlex for { <https://semopenalex.org/work/W2590473963> ?p ?o ?g. }
Showing items 1 to 76 of
76
with 100 items per page.
- W2590473963 endingPage "9560" @default.
- W2590473963 startingPage "9560" @default.
- W2590473963 abstract "9560 Background: Overall survival (OS) rates of patients with localized Ewing sarcoma family of tumors (ESFT) are >80% when treated with the MSKCC P6 protocol. However, it has been associated with a 5.8% incidence of secondary leukemias. A modified P6 (mP6) protocol with reduced exposure to chemotherapy is presented. The correlation between clinical outcome and the expression of proteins involved in active growth signaling pathways was explored. Methods: Thirty-one newly diagnosed ESFT patients were enrolled onto this phase II, single-arm, non-randomized protocol. A paraffin-embedded tissue array of 45 specimens was stained with the antibodies against c-KIT, AKT, p- AKT, p-mTOR, IGF-1R, IGFBP-3, MAPK, p27KIP1, and p70S6 kinase. Immunohistochemical staining was correlated with patient OS. Results: Twenty-four patients had loco-regional disease and 7 had metastases. The 4-year event-free survival (EFS) rate for patients with localized tumours is 83% and OS is 92%. The 3-year EFS rate for patients with distant metastases is 28% and OS rate is 42%. None of the patients experienced tumour progression before remission. All relapses occurred within 2 years from the end of treatment and local relapses (n=3) happened in patients who did not receive radiation therapy. No secondary malignancies have been observed, median follow-up of 4.3 years. In the univariate analysis only p-mTOR and p27KIP1 showed statistical significance to predict survival. A positive stain for p-mTOR (HR of 4,74 [95% CI (57, 121)]) was significantly (log-rank test, p=0,029) associated with better OS. Also, a positive stain for p27KIP1 (HR 6,87 [95% CI (77, 136)] was significantly (log-rank test, p=0,009) associated with better OS. Multivariate analysis show p-mTOR (HR: 5.57 with 95% CI: 0.7 to 44; p= 0.104) and p27 (HR: 3.2 [95% CI (1.02,10.2)] p=0.047) expression as independent prognostic factors of outcome. Conclusions: In this study, the mP6 protocol produced a complete remission rate of 83% at 4 years in non-metastatic ESFT reducing the risk of secondary malignancies. In our series, p-mTOR and p27KIP1protein overexpression were independently associated with better survival." @default.
- W2590473963 created "2017-03-03" @default.
- W2590473963 creator A5029326509 @default.
- W2590473963 creator A5035207944 @default.
- W2590473963 creator A5041042634 @default.
- W2590473963 creator A5044250695 @default.
- W2590473963 creator A5052068446 @default.
- W2590473963 creator A5064719496 @default.
- W2590473963 date "2011-05-20" @default.
- W2590473963 modified "2023-09-26" @default.
- W2590473963 title "Treatment of Ewing sarcoma family of tumors with a modified P6 protocol in children and adolescents: Analysis of growth signaling pathways expression and clinical outcome." @default.
- W2590473963 doi "https://doi.org/10.1200/jco.2011.29.15_suppl.9560" @default.
- W2590473963 hasPublicationYear "2011" @default.
- W2590473963 type Work @default.
- W2590473963 sameAs 2590473963 @default.
- W2590473963 citedByCount "0" @default.
- W2590473963 crossrefType "journal-article" @default.
- W2590473963 hasAuthorship W2590473963A5029326509 @default.
- W2590473963 hasAuthorship W2590473963A5035207944 @default.
- W2590473963 hasAuthorship W2590473963A5041042634 @default.
- W2590473963 hasAuthorship W2590473963A5044250695 @default.
- W2590473963 hasAuthorship W2590473963A5052068446 @default.
- W2590473963 hasAuthorship W2590473963A5064719496 @default.
- W2590473963 hasConcept C120665830 @default.
- W2590473963 hasConcept C121332964 @default.
- W2590473963 hasConcept C126322002 @default.
- W2590473963 hasConcept C142724271 @default.
- W2590473963 hasConcept C143998085 @default.
- W2590473963 hasConcept C144301174 @default.
- W2590473963 hasConcept C204232928 @default.
- W2590473963 hasConcept C2778256501 @default.
- W2590473963 hasConcept C38180746 @default.
- W2590473963 hasConcept C55493867 @default.
- W2590473963 hasConcept C61511704 @default.
- W2590473963 hasConcept C62478195 @default.
- W2590473963 hasConcept C65409693 @default.
- W2590473963 hasConcept C71924100 @default.
- W2590473963 hasConcept C86554907 @default.
- W2590473963 hasConcept C86803240 @default.
- W2590473963 hasConceptScore W2590473963C120665830 @default.
- W2590473963 hasConceptScore W2590473963C121332964 @default.
- W2590473963 hasConceptScore W2590473963C126322002 @default.
- W2590473963 hasConceptScore W2590473963C142724271 @default.
- W2590473963 hasConceptScore W2590473963C143998085 @default.
- W2590473963 hasConceptScore W2590473963C144301174 @default.
- W2590473963 hasConceptScore W2590473963C204232928 @default.
- W2590473963 hasConceptScore W2590473963C2778256501 @default.
- W2590473963 hasConceptScore W2590473963C38180746 @default.
- W2590473963 hasConceptScore W2590473963C55493867 @default.
- W2590473963 hasConceptScore W2590473963C61511704 @default.
- W2590473963 hasConceptScore W2590473963C62478195 @default.
- W2590473963 hasConceptScore W2590473963C65409693 @default.
- W2590473963 hasConceptScore W2590473963C71924100 @default.
- W2590473963 hasConceptScore W2590473963C86554907 @default.
- W2590473963 hasConceptScore W2590473963C86803240 @default.
- W2590473963 hasIssue "15_suppl" @default.
- W2590473963 hasLocation W25904739631 @default.
- W2590473963 hasOpenAccess W2590473963 @default.
- W2590473963 hasPrimaryLocation W25904739631 @default.
- W2590473963 hasRelatedWork W2013507592 @default.
- W2590473963 hasRelatedWork W2074694159 @default.
- W2590473963 hasRelatedWork W2166624570 @default.
- W2590473963 hasRelatedWork W2188035050 @default.
- W2590473963 hasRelatedWork W2331829818 @default.
- W2590473963 hasRelatedWork W2368991832 @default.
- W2590473963 hasRelatedWork W2377220232 @default.
- W2590473963 hasRelatedWork W2413531233 @default.
- W2590473963 hasRelatedWork W2765293154 @default.
- W2590473963 hasRelatedWork W3214902097 @default.
- W2590473963 hasVolume "29" @default.
- W2590473963 isParatext "false" @default.
- W2590473963 isRetracted "false" @default.
- W2590473963 magId "2590473963" @default.
- W2590473963 workType "article" @default.